EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
PTC Therapeutics, Inc. (PTCT) had EBIT Margin of 1.43% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$211.01M |
|
$15.90M |
|
$15.78M |
|
$195.23M |
|
$207.99M |
|
$3.02M |
|
$-26.09M |
|
$-23.07M |
|
$-23.07M |
|
$15.90M |
|
$15.90M |
|
$15.90M |
|
$15.90M |
|
$3.02M |
|
$8.23M |
|
78.47M |
|
87.12M |
|
$0.20 |
|
$0.20 |
|
| Balance Sheet Financials | |
$2.01B |
|
$56.97M |
|
$635.90M |
|
$2.64B |
|
$866.25M |
|
$1.84B |
|
$1.93B |
|
$2.80B |
|
$-155.76M |
|
$-634.57M |
|
$-155.76M |
|
79.93M |
|
| Cash Flow Statement Financials | |
$745.47M |
|
$-895.99M |
|
$28.59M |
|
$795.32M |
|
$686.30M |
|
$-109.02M |
|
$56.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.32 |
|
-- |
|
-- |
|
1.09 |
|
-15.31 |
|
92.52% |
|
1.43% |
|
|
EBIT Margin |
1.43% |
-- |
|
-10.94% |
|
7.53% |
|
$739.05M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.30 |
|
1.04 |
|
86.62 |
|
-10.21% |
|
-2.50% |
|
0.60% |
|
0.95% |
|
$-1.95 |
|
$8.48 |
|
$8.56 |
|